Protagonist Therapeutics (PTGX) Institutional Ownership $38.75 +0.26 (+0.68%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$39.89 +1.14 (+2.94%) As of 02/21/2025 06:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Protagonist Therapeutics (NASDAQ:PTGX)CurrentInstitutional OwnershipPercentage98.63%Number ofInstitutional Buyers(last 12 months)148TotalInstitutional Inflows(last 12 months)$551.01MNumber ofInstitutional Sellers(last 12 months)72TotalInstitutional Outflows(last 12 months)$259.35M Get PTGX Insider Trade Alerts Want to know when executives and insiders are buying or selling Protagonist Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data PTGX Institutional Buying and Selling by Quarter Protagonist Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/20/2025 Mackenzie Financial Corp21,349$824K0.0%+174.6%0.036% 2/19/2025 Toronto Dominion Bank340,974$13.16M0.0%N/A0.572% 2/19/2025 Cache Advisors LLC10,143$392K0.1%N/A0.017% 2/19/2025 GF Fund Management CO. LTD.1,251$48K0.0%N/A0.002% 2/17/2025 UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC287,911$11.11M0.0%-21.8%0.483% 2/17/2025 Woodline Partners LP582,327$22.48M0.2%+24.8%0.977% 2/17/2025 Soleus Capital Management L.P.275,000$10.62M0.7%N/A0.461% 2/17/2025 Tidal Investments LLC21,012$811K0.0%-4.8%0.035% 2/17/2025 State of Wyoming7,832$302K0.0%+11.9%0.013% 2/17/2025 Toronto Dominion Bank340,974$13.16M0.0%N/A0.572% Get the Latest News and Ratings for PTGX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Protagonist Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/17/2025 Stempoint Capital LP141,714$5.47M1.4%N/A0.238% 2/17/2025 Silvercrest Asset Management Group LLC84,426$3.26M0.0%-1.0%0.142% 2/17/2025 RTW Investments LP5,498,545$212.24M3.2%+1.3%9.226% 2/17/2025 Rafferty Asset Management LLC95,467$3.69M0.0%+6.2%0.160% 2/17/2025 ProShare Advisors LLC20,457$790K0.0%+30.5%0.034% 2/17/2025 Quantedge Capital Pte Ltd37,200$1.44M0.5%+12.8%0.062% 2/17/2025 Man Group plc157,963$6.10M0.0%+182.9%0.265% 2/17/2025 Nuveen Asset Management LLC151,197$5.84M0.0%-34.8%0.254% 2/17/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.37,055$1.43M0.0%+4.4%0.062% 2/17/2025Jefferies Financial Group Inc.1,489,495$57.50M0.3%-17.9%2.499% 2/17/2025 Focus Partners Wealth425,557$16.43M0.0%-0.3%0.714% 2/17/2025 Farallon Capital Management LLC5,930,006$228.90M1.2%+1.2%9.950% 2/17/2025 D. E. Shaw & Co. Inc.5,704$220K0.0%-78.7%0.010% 2/17/2025 Deutsche Bank AG137,932$5.32M0.0%+14.8%0.231% 2/17/2025 Driehaus Capital Management LLC339,698$13.11M0.1%-23.7%0.570% 2/17/2025 Deep Track Capital LP1,000,000$38.60M1.4%N/A1.678% 2/17/2025 Crestline Management LP12,681$489K0.0%N/A0.021% 2/17/2025 Braidwell LP20,109$776K0.0%N/A0.034% 2/17/2025 BVF Inc. IL1,900,015$73.34M2.5%+2.7%3.188% 2/17/2025 Bellevue Group AG23,718$916K0.0%+92.1%0.040% 2/17/2025 Bank of America Corp DE134,872$5.21M0.0%+13.4%0.226% 2/17/2025 BNP Paribas Financial Markets19,465$751K0.0%-4.1%0.033% 2/17/2025 Ameriprise Financial Inc.141,387$5.46M0.0%-1.7%0.237% 2/17/2025 Algert Global LLC17,720$684K0.0%-84.7%0.030% 2/17/2025 683 Capital Management LLC410,000$15.83M1.0%-2.4%0.688% 2/14/2025 Freestone Grove Partners LP6,644$256K0.0%N/A0.011% 2/14/2025 Comerica Bank20,558$794K0.0%-1.7%0.034% 2/14/2025 AQR Capital Management LLC150,097$5.79M0.0%+9.4%0.252% 2/14/2025 Northern Trust Corp628,580$24.26M0.0%+8.4%1.055% 2/14/2025 The Manufacturers Life Insurance Company 124,341$4.80M0.0%+7.4%0.209% Why Buffett and 100 members of Congress are Piling into this One Investment (Ad)This isn't just another investment. It might be the last retirement stock you'll ever need. But this window of opportunity is closing fast.Click here for the ticker >>>2/14/2025 Artia Global Partners LP293,851$11.34M4.1%+136.1%0.493% 2/14/2025 Boothbay Fund Management LLC20,188$779K0.0%N/A0.034% 2/14/2025 Virtus ETF Advisers LLC1,761$68K0.0%-34.3%0.003% 2/14/2025 New Vernon Capital Holdings II LLC3,061$118K0.1%N/A0.005% 2/14/2025 Two Sigma Securities LLC5,505$212K0.0%N/A0.009% 2/14/2025 Voya Investment Management LLC82,627$3.19M0.0%-27.4%0.139% 2/14/2025 Price T Rowe Associates Inc. MD1,392,652$53.76M0.0%+6.4%2.337% 2/14/2025 Eversept Partners LP678,787$26.20M2.3%+52.5%1.139% 2/14/2025 Hsbc Holdings PLC8,128$313K0.0%+38.5%0.014% 2/14/2025 State of Tennessee Department of Treasury27,076$1.05M0.0%-2.4%0.045% 2/14/2025 Tower Research Capital LLC TRC 7,369$284K0.0%+1,946.9%0.012% 2/14/2025 MetLife Investment Management LLC35,798$1.38M0.0%+5.9%0.060% 2/13/2025 Marshall Wace LLP19,716$761K0.0%-93.7%0.033% 2/13/2025 PEAK6 LLC9,000$347K0.0%N/A0.015% 2/13/2025 Affinity Asset Advisors LLC130,000$5.02M0.7%N/A0.218% 2/13/2025 Guggenheim Capital LLC19,078$736K0.0%+141.6%0.032% 2/13/2025 XTX Topco Ltd6,744$260K0.0%-54.4%0.011% 2/13/2025 Mariner LLC17,983$694K0.0%+12.5%0.030% 2/13/2025 Barclays PLC126,733$4.89M0.0%-0.2%0.213% 2/13/2025 Covestor Ltd1,643$63K0.0%+5,200.0%0.003% 2/13/2025 Kennedy Capital Management LLC321,526$12.41M0.3%+20.4%0.539% 2/13/2025 Capital Fund Management S.A.28,058$1.08M0.0%N/A0.047% 2/13/2025 Renaissance Technologies LLC221,167$8.54M0.0%+53.4%0.371% 2/13/2025 Legal & General Group Plc152,562$5.89M0.0%-3.1%0.256% 2/13/2025 Invesco Ltd.738,952$28.52M0.0%+13.1%1.240% 2/13/2025 Bank of Montreal Can6,250$241K0.0%+4.5%0.010% 2/13/2025 Cerity Partners LLC13,056$518K0.0%-8.3%0.022% 2/13/2025 Sierra Summit Advisors LLC22,282$860K0.2%+5.3%0.037% 2/13/2025 Envestnet Asset Management Inc.8,981$347K0.0%-29.7%0.015% 2/13/2025Aviva PLC14,627$565K0.0%N/A0.025% 2/13/2025 Wells Fargo & Company MN38,796$1.50M0.0%+32.1%0.065% 2/12/2025 ExodusPoint Capital Management LP29,870$1.15M0.0%N/A0.050% 2/12/2025 Massachusetts Financial Services Co. MA32,449$1.25M0.0%N/A0.054% 2/12/2025 Trexquant Investment LP92,788$3.58M0.0%+301.8%0.156% 2/12/2025 Geode Capital Management LLC1,377,063$53.17M0.0%+0.2%2.311% 2/12/2025 Franklin Resources Inc.88,870$3.43M0.0%+8.9%0.149% 2/12/2025 Alliancebernstein L.P.68,225$2.63M0.0%-16.7%0.114% 2/12/2025 Wellington Management Group LLP940,077$36.29M0.0%+3,025.4%1.577% 2/12/2025 Arrowstreet Capital Limited Partnership216,069$8.34M0.0%+36.7%0.363% 2/12/2025 Pictet Asset Management Holding SA296,511$11.45M0.0%+3,962.9%0.498% 2/12/2025 JPMorgan Chase & Co.576,977$22.27M0.0%+12.9%0.968% 2/12/2025 WINTON GROUP Ltd26,768$1.03M0.1%+3.0%0.045% 2/11/2025 Prudential Financial Inc.59,998$2.32M0.0%-1.3%0.101% 2/11/2025 Corebridge Financial Inc.31,155$1.20M0.0%-7.2%0.052% 2/11/2025 Advantage Alpha Capital Partners LP5,742$222K0.1%-49.3%0.010% 2/11/2025 Vanguard Group Inc.4,220,037$162.89M0.0%+0.1%7.081% 2/11/2025 KLP Kapitalforvaltning AS8,700$336K0.0%N/A0.015% 2/11/2025 Sei Investments Co.24,568$948K0.0%-30.0%0.041% 2/11/2025 American Century Companies Inc.928,286$35.83M0.0%+61.5%1.558% 2/11/2025 Summit Global Investments23,557$909K0.1%N/A0.040% Why Buffett and 100 members of Congress are Piling into this One Investment (Ad)This isn't just another investment. It might be the last retirement stock you'll ever need. But this window of opportunity is closing fast.Click here for the ticker >>>2/11/2025 Teacher Retirement System of Texas13,099$506K0.0%+18.7%0.022% 2/11/2025 Maryland State Retirement & Pension System20,170$779K0.0%+1.4%0.034% 2/10/2025 Cibc World Markets Corp5,468$211K0.0%N/A0.009% 2/10/2025 Skandinaviska Enskilda Banken AB publ 310,650$11.96M0.1%+35.0%0.521% 2/10/2025 Erste Asset Management GmbH13,500$526K0.0%N/A0.023% 2/10/2025 Swiss National Bank86,900$3.35M0.0%+1.2%0.146% 2/10/2025 Great Lakes Advisors LLC61,947$2.39M0.0%-11.0%0.104% 2/7/2025 Moran Wealth Management LLC15,961$616K0.0%+6.2%0.027% 2/7/2025 AlphaQuest LLC2,177$84K0.0%-90.9%0.004% 2/7/2025 PNC Financial Services Group Inc.1,441$56K0.0%-16.7%0.002% (Data available from 1/1/2016 forward) PTGX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of PTGX shares? During the previous two years, 226 institutional investors and hedge funds held shares of Protagonist Therapeutics. The most heavily invested institutionals were Farallon Capital Management LLC ($228.90M), RTW Investments LP ($212.24M), Vanguard Group Inc. ($162.89M), State Street Corp ($143.26M), BVF Inc. IL ($73.34M), Pacer Advisors Inc. ($72.43M), and Jefferies Financial Group Inc. ($57.50M).Learn more on PTGX's institutional investors. What percentage of Protagonist Therapeutics stock is owned by institutional investors? 98.63% of Protagonist Therapeutics stock is owned by institutional investors. Learn more on PTGX's institutional investor holdings. Which institutional investors have been buying Protagonist Therapeutics stock? Of the 183 institutional investors that purchased Protagonist Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BVF Inc. IL ($3.83M), Pacer Advisors Inc. ($1.88M), Cowen AND Company LLC ($1.66M), RTW Investments LP ($1.22M), Braidwell LP ($1.13M), State Street Corp ($1.10M), and Kynam Capital Management LP ($1.03M). How much institutional buying is happening at Protagonist Therapeutics? Institutional investors have bought a total of 29,583,043 shares in the last 24 months. This purchase volume represents approximately $921.39M in transactions. Which Protagonist Therapeutics major shareholders have been selling company stock? Of the 96 institutional investors that sold Protagonist Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: BVF Inc. IL ($1.99M), Kynam Capital Management LP ($1.26M), Farallon Capital Management LLC ($1.04M), Point72 Asset Management L.P. ($985.03K), Deutsche Bank AG ($789.41K), Marshall Wace LLP ($700.37K), and Perceptive Advisors LLC ($671.01K). How much institutional selling is happening at Protagonist Therapeutics? Institutional investors have sold a total of 13,563,556 shares in the last 24 months. This volume of shares sold represents approximately $390.60M in transactions. Related Companies Qiagen Major Shareholders Ascendis Pharma A/S Major Shareholders Roivant Sciences Major Shareholders Revolution Medicines Major Shareholders Legend Biotech Major Shareholders BridgeBio Pharma Major Shareholders Axsome Therapeutics Major Shareholders Blueprint Medicines Major Shareholders Elanco Animal Health Major Shareholders Lantheus Major Shareholders This page (NASDAQ:PTGX) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | Sponsored[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWhat is this southern state hiding?The financial press had a field day this week after President Donald Trump and Department of Government Effici...Stansberry Research | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Protagonist Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Protagonist Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PTGX Stock Alerts